Novo Nordisk A/S NONOF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -57.05% | 81.43% | 33.74% | -22.26% | -1.57% |
| Total Depreciation and Amortization | 1.97% | 14.42% | -5.17% | -10.97% | 7.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 227.50% | 112.24% | -253.93% | 699.03% | -47.40% |
| Change in Net Operating Assets | 139.83% | -263.92% | 508.64% | -164.32% | 155.55% |
| Cash from Operations | 127.75% | 217.62% | -83.56% | 13.66% | 82.15% |
| Capital Expenditure | -11.35% | 38.33% | -34.56% | 4.28% | -17.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 77.95% | 98.41% | -1,305.70% | -440.80% | -92.13% |
| Cash from Investing | -8.30% | 72.51% | -176.17% | -12.51% | -154.63% |
| Total Debt Issued | 17.49% | -47.82% | 4,194.53% | -98.42% | 65.31% |
| Total Debt Repaid | -2,019.48% | -6.85% | -0.61% | 98.23% | -439.04% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -45.79% | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | -- | 100.00% | -- | -- |
| Other Financing Activities | -249.86% | -- | -- | -- | -207.52% |
| Cash from Financing | -9.06% | -159.44% | 271.50% | 62.82% | -1,205.64% |
| Foreign Exchange rate Adjustments | 118.72% | -361.62% | 67.42% | 108.01% | -915.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 534.85% | 4.58% | -140.97% | 168.55% | -194.96% |